Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression

American Journal of Geriatric Psychiatry

Volumn 19, Issue 12, 2011, Pages 1016-1025

  Smith, Gwenn S ^a,b   Kahn, Alan ^b   Sacher, Julia ^b,e   Rusjan, Pablo ^b   Van Eimeren, Thilo ^c   Flint, Alastair ^b,c,d   Wilson, Alan A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

Author keywords

aging; citalopram; depression; glucose metabolism; positron emission tomography (PET); selective serotonin reuptake inhibitors; serotonin; serotonin transporter

Indexed keywords

3 AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL)ENZONITRILE C 11; CARBON 11; CITALOPRAM; FLUORODEOXYGLUCOSE F 18; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL GENETICS; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; GERIATRIC DISORDER; GERONTOPSYCHIATRY; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HAMILTON SCALE; HUMAN; LIMBIC SYSTEM; MAJOR DEPRESSION; MALE; NEUROIMAGING; NEUROPHARMACOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OPEN STUDY; POSITRON EMISSION TOMOGRAPHY; PSYCHOPHARMACOTHERAPY; SEROTONINERGIC SYSTEM; TREATMENT OUTCOME;

EID: 82255162859     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318227f83f     Document Type: Article

References (39)

1. Diaconescu A, Kramer E, Hermann C, et al: The functional neuroanatomy of recovery of affective symptoms and cognitive deficits in geriatric depression. Hum Brain Mapp 2010 Sep 30. doi: 10.1002/hbm.21135. [Epub ahead of print].
2. Smith G, Kramer E, Hermann C, et al: Serotonin modulation of cerebral glucose metabolism in geriatric depression. Am J Geriatric Psychiatry 2002; 10:715-723 (Pubitemid 35315707)
3. Smith G, Reynolds C, Houck P, et al: The glucose metabolic response to total sleep deprivation, recovery sleep and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression. Am J Geriatr Psychiatry 2002; 10(5):561-567 (Pubitemid 34984392)
4. Smith G, Kramer E, Hermann C, et al: The functional neuroanatomy of geriatric depression. Int J Geriatr Psychiatry 2009; 24:798-808
5. Meyer JH, Wilson AA, Ginovart N, et al: Occupancy of SERTs by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry 2001; 158(11):1843-1849 (Pubitemid 33054777)
6. Meyer JH, Wilson AA, Sagrati S, et al: Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry 2004; 161(5):826-835 (Pubitemid 38625335)
7. Steinbusch H: Distribution of serotonin immunoreactivity in the central nervous system of the rat. Neuroscience 1981; 6:557-618 (Pubitemid 11102583)
8. Varn̈as K, Halldin C, Hall H: Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 2004; 22(3):246-260 (Pubitemid 38891003)
9. Smith G, Kramer E, Hermann C, et al: Serotonin modulation of cerebral glucose metabolism in depressed older adults. Biol Psychiatry 2009; 66(3):259-266
10. Smith G, Kahn A, Hanratty K, et al: Serotonin transporter occupancy by citalopram treatment in geriatric depression. Neuroimage 2008; 41(2):T168
11. Sackeim HA, Roose SP, Lavori PW: Determining the duration of antidepressant treatment: application of signal detection methodology and the need for duration adaptive designs (DAD). Biol Psychiatry 2006; 59(6):483-492 (Pubitemid 43320535)
12. First M, Spitzer R, Gibbon M, et al: Structured Clinical Interview forDSM-IV Axis 1 Disorders-Patient Edition (SCID-I/P).New York, New York: Psychiatric Institute, 1995
13. Folstein M, Folstein S, McHugh P: Mini-Mental State. J Psychiatr Res 1976; 12:189-198
14. National Institute of Mental Health: Clinical global impressions, in: Manual for the ECDEU Assessment Battery. 2nd ed. Edited by Guy W, Bonato RR. Rockville, MD: National Institute of Mental Health, 1976
15. Hamilton M: A rating scale for depression. J Neurol, Neurosurg Psychiatry 1960; 23:56-62
16. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55
17. Foglia JP, Pollock BG, Kirshner MA, et al: Plasma levels of citalopram enantiomers and metabolites in elderly Patients. Psychopharmacol Bull 1997; 33(1):109-112 (Pubitemid 27184203)
18. Wilson AA, Ginovart N, Hussey D, et al: In vitro and in vivo characterization of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. Nuclear Med Biol 2002; 29(5):509-515 (Pubitemid 34667112)
19. Hamacher K, Coenen H, Sẗocklin G: Efficient stereospecific synthesis of no-carrier-added 2-[18f]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nuclear Med 1986; 27;235-238 (Pubitemid 17024868)
20. Lemaire C, Damhaut B, Lauricella C, et al: Fast [18F]FDG synthesis by alkaline hydrolysis on a low polarity solid phase support. J Labelled Comp Radiopharm 2002; 45:435-447 (Pubitemid 34464649)
21. Rusjan P, Mamo D, Ginovart N, et al: An automated method for the extraction of regional data from PET images. Psychiatry Res 2006; 147(1):79-89 (Pubitemid 44067435)
22. Ginovart N, Wilson AA, Meyer JH, et al: Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab 2001; 21(11):1342-1353 (Pubitemid 33130946)
23. Frankle WG, Slifstein M, Gunn RN, et al: Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. J Nucl Med 2006; 47(5):815-826 (Pubitemid 46768446)
24. Kim JS, Ichise M, Sangare J, et al: PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method. J Nucl Med 2006; 47(2):208-214 (Pubitemid 46780884)
25. Parsey RV, Kent JM, Oquendo MA, et al: Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography. Biol Psychiatry 2006; 59(9): 821-828
26. Cseĺenyi Z, Olsson H, Farde L, et al: Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457. Neuroimage 2002; 17(1): 47-60
27. Turkheimer FE, Banati RB, Visvikis D, et al: Modeling dynamic PET-SPECT studies in the wavelet domain. J Cereb Blood Flow Metab 2000; 20(5):879-893 (Pubitemid 30317063)
28. Takikawa S, Dhawan V, Spetsieris P, et al:Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 1993; 188(1):131-136 (Pubitemid 23183112)
29. Little JT, Reynolds CF III, Dew MA, et al: How common is resistance to treatment in recurrent, nonpsychotic geriatric depression? Am J Psychiatry 1998; 155(8):1035-1038 (Pubitemid 28357727)
30. AlexopoulosGS, Murphy CF,Gunning-Dixon FM, et al: Microstructuralwhite matter abnormalities and remission of geriatric depression. Am J Psychiatry 2008; 165(2):238-244 (Pubitemid 351704524)
31. Fletcher PC, Frith CD, Baker SC, et al: Themind's eye-precuneus activation in memory-related imagery. Neuroimage 1995; 2(3): 195-200
32. Liotti M, Mayberg HS, Brannan SK, et al: Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders. Biol Psychiatry 2000; 48(1): 30-42 (Pubitemid 30407147)
33. Tataranni PA, Gautier JF, Chen K, Uecker A, et al: Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci 1999; 96(8):4569-4574 (Pubitemid 29190377)
34. Thomas AJ,HendriksenM, Piggott M, et al: A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression. Neuropathol Appl Neurobiol 2006; 32(3):296-303
35. Milak M, Kumar JSD, Severance AJ, et al: Altered binding in baboons of [11C]CUMI-101, a 5-HT1A agonist PET tracer, in response to intravenous citalopram. Neuroimage 2008; 41(S2):T162
36. Mayberg HS, Silva JA, Brannan SK, et al: The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002; 159(5): 728-737 (Pubitemid 34465045)
37. McBean D, Ritchie I, Olverman H, et al: Effects of the specific serotonin reuptake inhibitor, citalopram, upon local cerebral blood flow and glucose utilization in the rat. Brain Res 1999; 847(1): 80-84 (Pubitemid 29516707)
38. Hinz R, Selvaraj S, Murthy NV, et al: Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls. J Cereb Blood Flow Metab 2008; 28(8):1478-1490
39. Kish SJ, Furukawa Y, Chang LJ, et al: Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl Med Biol 2005; 32(2): 123-128 (Pubitemid 40260663)